Compare STTK & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STTK | MYFW |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 220.8M |
| IPO Year | 2020 | 2018 |
| Metric | STTK | MYFW |
|---|---|---|
| Price | $3.14 | $26.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $4.00 | ★ $24.25 |
| AVG Volume (30 Days) | ★ 328.1K | 26.2K |
| Earning Date | 11-06-2025 | 01-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 391.62 |
| EPS | N/A | ★ 1.28 |
| Revenue | $1,000,000.00 | ★ $95,514,000.00 |
| Revenue This Year | N/A | $15.96 |
| Revenue Next Year | N/A | $13.77 |
| P/E Ratio | ★ N/A | $20.10 |
| Revenue Growth | N/A | ★ 19.92 |
| 52 Week Low | $0.69 | $17.10 |
| 52 Week High | $3.38 | $26.28 |
| Indicator | STTK | MYFW |
|---|---|---|
| Relative Strength Index (RSI) | 71.00 | 74.03 |
| Support Level | $1.93 | $23.72 |
| Resistance Level | $3.30 | $26.28 |
| Average True Range (ATR) | 0.23 | 0.56 |
| MACD | 0.09 | 0.21 |
| Stochastic Oscillator | 80.69 | 89.95 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.